|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-4-16
|
|
pubmed:abstractText |
Androgens mediate the growth of prostate cancer cells. The predictive value of androgen receptor immunostaining in patient outcome is controversial. We studied the expression of androgen receptors in a large series of patients with node positive cancer, and correlated the results with clinical progression and survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
161
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1233-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10081876-Adenocarcinoma,
pubmed-meshheading:10081876-Aged,
pubmed-meshheading:10081876-Follow-Up Studies,
pubmed-meshheading:10081876-Humans,
pubmed-meshheading:10081876-Lymphatic Metastasis,
pubmed-meshheading:10081876-Male,
pubmed-meshheading:10081876-Middle Aged,
pubmed-meshheading:10081876-Predictive Value of Tests,
pubmed-meshheading:10081876-Prostatic Neoplasms,
pubmed-meshheading:10081876-Receptors, Androgen,
pubmed-meshheading:10081876-Risk Factors,
pubmed-meshheading:10081876-Survival Rate,
pubmed-meshheading:10081876-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
|
|
pubmed:affiliation |
Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article
|
